小儿智力糖浆治疗注意缺陷多动障碍患儿的临床观察  

Clinical Observation of Xiaoer Zhili Syrup in the Treatment of Sleep Disorder in Children with ADHD

作　　者：毛春婷[1] 胡正[1] 谢玲[1] 苏志暖[1] 宋彩云[1] 李晓南[1] 

机构地区：[1]南京医科大学附属南京儿童医院儿保科,南京200018

出　　处：《中国药房》2012年第4期319-321,共3页China Pharmacy

摘　　要：目的:观察小儿智力糖浆治疗注意缺陷多动障碍(ADHD)患儿的睡眠、注意力商数的临床疗效。方法:选择我院56例ADHD患儿,给予小儿智力糖浆治疗,每次10mL,tid,连续治疗3个月。另选取53例身心健康儿童进行对照;并运用《儿童睡眠状况调查问卷》(CSHQ)对ADHD患儿在小儿智力糖浆治疗前、后进行整合视听连续执行测试,比较治疗前后ADHD患儿的睡眠及注意力商数情况。结果:ADHD患儿治疗前CSHQ得分高于健康儿童(P<0.05),且睡眠障碍发生率达53.7%。小儿智力糖浆治疗后ADHD患儿CSHQ得分较治疗前明显降低(P<0.05),且治疗后注意力商数显著提高(P<0.05)。ADHD组用药期间未见明显不良反应。结论:小儿智力糖浆可改善ADHD患儿的睡眠障碍和提高其注意力商数,且安全性较好。OBJECTIVE： To observe the therapeutic efficacy of Xiaoer zhili syrup on sleep disorders, attentive quotients and re- sponsive control quotients in children with ADHD. METHODS： We surveyed the sleep quality of 56 children in ADHD group （treated with Xiaoer zhili syrup 10 mL, tid, 3 months） before and after treatment and 53 normal children using Children Sleep Habit Questionnaire （CSHQ）. Do IVA-CPT in children of ADHD group before and after treatment. Compared the situation of sleep and attentive quotients of ADHD children before and after treatment. RESULTS： The scores of CSHQ in ADHD group before treat- ment were higher than normal children, there was statistical significance（P〈0.05）. 53.7% children suffered from sleep disorders in ADHD group. The scores of CSHQ in ADHD group after treatment were lower than before treatment （P〈0.05）. The attentive quo- tients of ADHD group after treatment were higher than before treatment （P〈0.05）, but responsive control quotients had no signifi- cant change. There were no significant ADRs found in ADHD group. CONCLUSION： Xiaoer zhili syrup can improve sleep disor- ders and attentive quotients of children with ADHD with good safety.

关 键 词：注意缺陷多动障碍 睡眠障碍 小儿智力糖浆 

分 类 号：R729[医药卫生—儿科]